JP2010503629A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010503629A5 JP2010503629A5 JP2009527741A JP2009527741A JP2010503629A5 JP 2010503629 A5 JP2010503629 A5 JP 2010503629A5 JP 2009527741 A JP2009527741 A JP 2009527741A JP 2009527741 A JP2009527741 A JP 2009527741A JP 2010503629 A5 JP2010503629 A5 JP 2010503629A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- alkyl
- benzoxazol
- methyl
- piperazin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120733.8 | 2006-09-15 | ||
| EP06120733A EP1900729A1 (en) | 2006-09-15 | 2006-09-15 | Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors |
| PCT/EP2007/007983 WO2008031594A1 (en) | 2006-09-15 | 2007-09-13 | Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010503629A JP2010503629A (ja) | 2010-02-04 |
| JP2010503629A5 true JP2010503629A5 (enExample) | 2010-10-28 |
| JP5325105B2 JP5325105B2 (ja) | 2013-10-23 |
Family
ID=37717673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009527741A Expired - Fee Related JP5325105B2 (ja) | 2006-09-15 | 2007-09-13 | ヤヌスキナーゼ阻害剤として有用なベンゾオキサゾールおよびオキサゾロピリジン |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8629168B2 (enExample) |
| EP (2) | EP1900729A1 (enExample) |
| JP (1) | JP5325105B2 (enExample) |
| KR (1) | KR20090064389A (enExample) |
| CN (1) | CN101516860B (enExample) |
| AR (1) | AR062786A1 (enExample) |
| AT (1) | ATE532774T1 (enExample) |
| AU (1) | AU2007296916B2 (enExample) |
| BR (1) | BRPI0716841A2 (enExample) |
| CA (1) | CA2660987A1 (enExample) |
| CL (1) | CL2007002669A1 (enExample) |
| CO (1) | CO6150142A2 (enExample) |
| CR (1) | CR10639A (enExample) |
| EA (1) | EA200900388A1 (enExample) |
| ES (1) | ES2377148T3 (enExample) |
| GT (1) | GT200900056A (enExample) |
| IL (1) | IL196860A0 (enExample) |
| MA (1) | MA30723B1 (enExample) |
| MX (1) | MX2009002812A (enExample) |
| NO (1) | NO20091469L (enExample) |
| PA (1) | PA8748101A1 (enExample) |
| PE (1) | PE20080842A1 (enExample) |
| PL (1) | PL2066647T3 (enExample) |
| PT (1) | PT2066647E (enExample) |
| SM (1) | SMP200900023B (enExample) |
| TN (1) | TN2009000070A1 (enExample) |
| TW (1) | TW200819444A (enExample) |
| UY (1) | UY30587A1 (enExample) |
| WO (1) | WO2008031594A1 (enExample) |
| ZA (1) | ZA200900477B (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2467670B (en) | 2007-10-04 | 2012-08-01 | Intellikine Inc | Chemical entities and therapeutic uses thereof |
| US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
| BRPI0915231A2 (pt) | 2008-07-08 | 2018-06-12 | Intellikine Inc | compostos inibidores de quinase e métodos de uso |
| MX2011000211A (es) * | 2008-07-15 | 2011-03-03 | Sanofi Aventis | Oxazolopirimidinas como agonistas del receptor edg-1. |
| US20100041891A1 (en) * | 2008-08-12 | 2010-02-18 | Takeda Pharmaceutical Company Limited | Amide compound |
| US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
| WO2010061971A1 (ja) | 2008-11-28 | 2010-06-03 | 興和株式会社 | ピリジン－３－カルボキシアミド誘導体 |
| WO2011078360A1 (ja) | 2009-12-24 | 2011-06-30 | 武田薬品工業株式会社 | アミド化合物 |
| TWI485153B (zh) * | 2010-01-13 | 2015-05-21 | Sanofi Aventis | ２，５，７－經取代唑并嘧啶衍生物 |
| US9295673B2 (en) | 2011-02-23 | 2016-03-29 | Intellikine Llc | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof |
| US8580816B2 (en) * | 2011-07-07 | 2013-11-12 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
| US8907093B2 (en) * | 2011-07-07 | 2014-12-09 | Sanofi | Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring |
| CN103102359B (zh) * | 2011-11-15 | 2016-11-09 | 江苏先声药业有限公司 | 嘧啶类化合物及其应用 |
| ES3018133T3 (en) | 2011-11-30 | 2025-05-14 | Univ Emory | Jak inhibitors for use in the prevention or treatment of a viral disease caused by a coronaviridae |
| WO2014075318A1 (zh) * | 2012-11-19 | 2014-05-22 | 江苏先声药业有限公司 | 嘧啶类化合物及其应用 |
| WO2014153509A1 (en) | 2013-03-22 | 2014-09-25 | Millennium Pharmaceuticals, Inc. | Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase |
| CN103664759A (zh) * | 2013-12-06 | 2014-03-26 | 常熟市联创化学有限公司 | 一种3-羟基-2-硝基吡啶的制备方法 |
| WO2015117147A1 (en) | 2014-02-03 | 2015-08-06 | Quadriga Biosciences, Inc. | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents |
| BR112016017993A2 (pt) | 2014-02-03 | 2017-08-08 | Quadriga Biosciences Inc | Gama-aminoácidos beta-substituídos e análogos como agentes quimioterapêuticos |
| WO2016047678A1 (ja) * | 2014-09-25 | 2016-03-31 | 武田薬品工業株式会社 | 複素環化合物 |
| KR20180035894A (ko) | 2015-08-03 | 2018-04-06 | 콰드리가 바이오사이언시스 인코포레이티드 | 화학치료제로서의 베타-치환된 베타-아미노산 및 유사체 및 이들의 용도 |
| US20220372135A1 (en) | 2019-09-27 | 2022-11-24 | Disc Medicine, Inc. | Methods for treating myelofibrosis and related conditions |
| KR20230012539A (ko) | 2020-05-13 | 2023-01-26 | 디스크 메디슨, 인크. | 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체 |
| WO2022251597A1 (en) | 2021-05-28 | 2022-12-01 | Verge Analytics, Inc. | Methods of treating neurological disorders with modulators of ribosomal protein s6 kinase alpha-1 (rsk1) and ribosomal protein s6 kinase alpha-3 (rsk2) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60037345T2 (de) * | 1999-12-10 | 2008-11-13 | Pfizer Products Inc., Groton | Pyrrolo(2,3-d)pyrimidin-Verbindungen |
| SE0301373D0 (sv) * | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Novel compounds |
| DE10344223A1 (de) * | 2003-09-24 | 2005-04-21 | Merck Patent Gmbh | 1,3-Benzoxazolylderivate als Kinase-Inhibitoren |
| GB0402140D0 (en) * | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
| EP1674467A1 (en) * | 2004-12-22 | 2006-06-28 | 4Sc Ag | 2,5- and 2,6-disubstituted benzazole derivatives useful as protein kinase inhibitors |
| CA2620127A1 (en) * | 2005-09-02 | 2007-03-08 | F. Hoffmann-La Roche Ag | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| WO2008009458A1 (en) * | 2006-07-21 | 2008-01-24 | Novartis Ag | 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
-
2006
- 2006-09-15 EP EP06120733A patent/EP1900729A1/en not_active Ceased
-
2007
- 2007-09-12 UY UY30587A patent/UY30587A1/es not_active Application Discontinuation
- 2007-09-13 EP EP07802300A patent/EP2066647B1/en active Active
- 2007-09-13 WO PCT/EP2007/007983 patent/WO2008031594A1/en not_active Ceased
- 2007-09-13 AR ARP070104060A patent/AR062786A1/es unknown
- 2007-09-13 AT AT07802300T patent/ATE532774T1/de active
- 2007-09-13 MX MX2009002812A patent/MX2009002812A/es active IP Right Grant
- 2007-09-13 JP JP2009527741A patent/JP5325105B2/ja not_active Expired - Fee Related
- 2007-09-13 PT PT07802300T patent/PT2066647E/pt unknown
- 2007-09-13 ES ES07802300T patent/ES2377148T3/es active Active
- 2007-09-13 AU AU2007296916A patent/AU2007296916B2/en not_active Ceased
- 2007-09-13 PL PL07802300T patent/PL2066647T3/pl unknown
- 2007-09-13 BR BRPI0716841-1A2A patent/BRPI0716841A2/pt not_active IP Right Cessation
- 2007-09-13 EA EA200900388A patent/EA200900388A1/ru unknown
- 2007-09-13 CA CA002660987A patent/CA2660987A1/en not_active Abandoned
- 2007-09-13 US US12/440,298 patent/US8629168B2/en not_active Expired - Fee Related
- 2007-09-13 KR KR1020097005248A patent/KR20090064389A/ko not_active Withdrawn
- 2007-09-13 PE PE2007001237A patent/PE20080842A1/es not_active Application Discontinuation
- 2007-09-13 CN CN2007800339907A patent/CN101516860B/zh not_active Expired - Fee Related
- 2007-09-14 CL CL200702669A patent/CL2007002669A1/es unknown
- 2007-09-14 PA PA20078748101A patent/PA8748101A1/es unknown
- 2007-09-14 TW TW096134606A patent/TW200819444A/zh unknown
-
2009
- 2009-01-21 ZA ZA200900477A patent/ZA200900477B/xx unknown
- 2009-02-02 IL IL196860A patent/IL196860A0/en unknown
- 2009-02-26 CR CR10639A patent/CR10639A/es not_active Application Discontinuation
- 2009-02-27 TN TN2009000070A patent/TN2009000070A1/fr unknown
- 2009-03-10 CO CO09024347A patent/CO6150142A2/es unknown
- 2009-03-11 GT GT200900056A patent/GT200900056A/es unknown
- 2009-03-30 MA MA31738A patent/MA30723B1/fr unknown
- 2009-04-09 SM SM200900023T patent/SMP200900023B/it unknown
- 2009-04-15 NO NO20091469A patent/NO20091469L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010503629A5 (enExample) | ||
| US7598249B2 (en) | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase | |
| KR100706736B1 (ko) | 페닐헤테로알킬아민 유도체의 신규 용도 | |
| US7541359B2 (en) | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase | |
| JP4185154B2 (ja) | 中枢神経系障害治療用の置換モルホリン化合物 | |
| TWI324602B (en) | Aryl-isoxazolo-4-yl-oxadiazole derivatives | |
| JP2019112449A (ja) | 嚢胞性線維症を処置するための新規化合物およびこれらの医薬組成物 | |
| BR112015027114B1 (pt) | Compostos inibidores seletivos de histona desacetilase e seu uso | |
| NZ511481A (en) | Benzamide derivatives and their use as apoB-100 secretion inhibitors | |
| JP2009538358A (ja) | 脂肪酸アミド加水分解酵素のオキサゾリルピペリジン・モジュレーター | |
| US20090062294A1 (en) | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase | |
| KR20110059723A (ko) | 세포내 칼슘을 조절하는 화합물 | |
| JP6975515B2 (ja) | Ｔｒｐａ１モデュレーターとしてのスルホニルシクロアルキルカルボキサミド化合物 | |
| EP1286670A2 (en) | Use of therapeutic benzamide derivatives | |
| WO2005105100A1 (en) | Morpholine compounds | |
| JPWO2017014170A1 (ja) | 複素環化合物 | |
| WO2010068453A1 (en) | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase | |
| WO2011051282A1 (en) | (1,1, 1,3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) phenyl derivatives, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis | |
| TW201114761A (en) | Compounds that modulate intracellular calcium | |
| CN101511785A (zh) | 取代的苄基胺化合物 | |
| CN103864754A (zh) | 五元唑类杂环化合物及其制备方法、药物组合物和用途 | |
| JP2008506766A (ja) | ヒスタミン−３受容体拮抗薬 | |
| RU2445308C2 (ru) | Замещенные производные оксазола и их применение в качестве ингибиторов тирозинкиназы | |
| JP4880678B2 (ja) | 肝臓のカルニチンパルミトイルトランスフェラーゼ（ｌ−ｃｐｔ１）阻害剤として有用なスルホンアミド誘導体 | |
| JP3012338B2 (ja) | アリールおよびヘテロアリールアルコキシナフタレン誘導体 |